State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.45B |
| 2 |
Analog Devices
ADI
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$1.24B |
| 4 |
Tesla
TSLA
|
+$989M |
| 5 |
Match Group
MTCH
|
+$950M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.84B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.43B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$629M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$528M |
| 5 |
Oracle
ORCL
|
+$440M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.19% |
| 2 | Financials | 14.6% |
| 3 | Healthcare | 13.28% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
iShares Core US REIT ETF
USRT
$4.6B
| $3.09M | ﹤0.01% |
52,700
+10,200
| +24% | +$620K |
|
3327
CollPlant Biotechnologies
CLGN
$6.25M
| $3.08M | ﹤0.01% |
182,266
+5,776
| +3% | +$104K |
|
3328
TransAlta
TAC
$3.95B
| $3.06M | ﹤0.01% |
288,893
+769
| +0.3% | +$7.71K |
|
3329
ARS Pharmaceuticals
SPRY
$551M
| $3.04M | ﹤0.01% |
305,069
+80,750
| +36% | +$1.99M |
|
3330
Nathan's Famous
NATH
$403M
| $3.04M | ﹤0.01% |
49,681
-500
| -1% | -$32.9K |
|
3331
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| $3.03M | ﹤0.01% |
33,806
+4,792
| +17% | +$435K |
|
|
HARP
3332
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.03M | ﹤0.01% |
38,372
-94,465
| -71% | -$9.5M |
|
3333
Black Diamond Therapeutics
BDTX
$110M
| $3.01M | ﹤0.01% |
355,703
+21,352
| +6% | +$211K |
|
3334
Intercorp Financial Services
IFS
$6.55B
| $3M | ﹤0.01% |
134,117
-5,529
| -4% | -$121K |
|
|
MILE
3335
DELISTED
Metromile, Inc. Common Stock
MILE
| $2.99M | ﹤0.01% |
843,033
+77,167
| +10% | +$435K |
|
3336
Duolingo
DUOL
$5.71B
| $2.98M | ﹤0.01% |
+17,900
| New | +$2.72M |
|
|
ADN
3337
DELISTED
Advent Technologies
ADN
| $2.97M | ﹤0.01% |
11,394
+1,542
| +16% | +$375K |
|
|
PZN
3338
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $2.97M | ﹤0.01% |
302,138
+5,699
| +2% | +$61K |
|
3339
Sight Sciences
SGHT
$386M
| $2.95M | ﹤0.01% |
+130,084
| New | +$4.28M |
|
|
DAWN
3340
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.94M | ﹤0.01% |
+124,032
| New | +$2.97M |
|
|
ADAP
3341
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.94M | ﹤0.01% |
567,209
+307,627
| +119% | +$1.38M |
|
3342
GeneDx Holdings
WGS
$2.08B
| $2.94M | ﹤0.01% |
+11,742
| New | +$4.03M |
|
|
SOLY
3343
DELISTED
Soliton, Inc.
SOLY
| $2.93M | ﹤0.01% |
143,844
+17,804
| +14% | +$381K |
|
3344
Ericsson
ERIC
$33.3B
| $2.92M | ﹤0.01% |
261,980
-130,271
| -33% | -$1.54M |
|
|
NBEV
3345
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $2.92M | ﹤0.01% |
2,097,325
+128,411
| +7% | +$234K |
|
3346
KALA BIO
KALA
$14.2M
| $2.91M | ﹤0.01% |
445
+116
| +35% | +$1M |
|
|
AFIB
3347
DELISTED
Acutus Medical Inc
AFIB
| $2.9M | ﹤0.01% |
328,256
+109,588
| +50% | +$1.44M |
|
|
DESP
3348
DELISTED
Despegar.com
DESP
| $2.89M | ﹤0.01% |
240,061
+290
| +0.1% | +$3.57K |
|
|
ETNB
3349
DELISTED
89bio
ETNB
| $2.89M | ﹤0.01% |
147,403
-925
| -0.6% | -$16.9K |
|
3350
Viemed Healthcare
VMD
$363M
| $2.88M | ﹤0.01% |
518,686
+1,851
| +0.4% | +$12K |
|
Similar funds
State Street's Q3 2021 Portfolio in Review
As of Q3 2021, State Street held 4,773 positions worth $1.89T, down 0.28% from $1.9T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
State Street's Q3 2021 filing shows 298 new, 2,370 increased, 1,521 reduced and 88 closed positions. Its largest new stake was GXO Logistics: 2,520,396 shares worth $198M. The largest sale was Alexion Pharmaceuticals, an estimated $1.84B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q3 2021 buy was GXO Logistics: 2,520,396 shares worth $198M.
- State Street added most to Moderna in Q3 2021, an estimated $2.45B increase.
- State Street's biggest Q3 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $629M.
- State Street fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.84B.
- State Street's ten largest holdings make up 21% of its $1.89T portfolio in Q3 2021.
- State Street opened 298 new positions and closed 88 in Q3 2021.
- State Street's portfolio value fell 0.28% quarter-over-quarter to $1.89T.
Based on State Street's 13F filing for Q3 2021, filed 15 Nov 2021.